In KRAS-WT patients, the high expression of KRAS mRNA is significantly associated with poor prognosis in PAAD (p = 0.0112) and LUAD (p = 0.0105) but not in COAD (p = 0.1145) (Fig. 7C). Here, KRAS is linked to pancreatic adenocarcinoma.